Mirtazapine Tablet, Film Coated
Product Images NDC 43353-378

3 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 43353-378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 30 mg (43353 0378 15)

Bottle Label 30 mg (43353 0378 15)
Label for Mirtazapine 30 mg film-coated tablets, containing 15 tablets. The label includes storage instructions, manufacturer information as Apotex Inc., Toronto, Canada, and repackager Aphena Pharma Solutions - Tennessee, LLC. The product is marked as RX only with NDC 43353-0378-15.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of the active ingredient mirtazapine, showing its molecular framework and arrangement of rings and atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.